False World Vs. Real World: A Strong Argument for RWD

Lucy Brake speaks to Mike Rea, CEO of IDEA Pharma, about how he believes real world evidence impacts current development and trials processes, and the ways in which pharma can take best take advantage of all this offers. Read entire article here. (Source: eyeforpharma, May 16, 2013)

You might also be interested in:

Real World Data Capabilities: Benchmarking Pharma Companies October 30, 2018
Gottlieb Touts Potential of RWE, RWD January 30, 2019
RWE: Opportunity, Challenges and Sourcing Simplified November 30, 2018
Breaking Through the Hype of Real-World Evidence January 19, 2019
Eyeforpharma Webinar to Spotlight Blockchain June 25, 2018
FirstWord Report Looks at Pharma Perspective on RWD October 30, 2018
Time to Market: Accelerating Market Access January 4, 2019